Djibouti vs Venezuela (Bolivarian Republic of): Proportion of the target population who received
Djibouti
48.0%
in 2024
Venezuela (Bolivarian Republic of)
51.0%
in 2024
Djibouti rank
181st
Venezuela (Bolivarian Republic of) rank
179th
Proportion of the target population who received over time
- Djibouti
- Venezuela (Bolivarian Republic of)
How they compare
Venezuela (Bolivarian Republic of) currently reports 51.0% against 48.0% in Djibouti, a difference of 3.0%.
That makes Venezuela (Bolivarian Republic of)'s figure about 1.1 times Djibouti's.
The two have swapped places 1 time across 13 shared years of data; in 2012 it was Djibouti ahead.
Djibouti ranks 181st and Venezuela (Bolivarian Republic of) ranks 179th of 193 countries.
Djibouti has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Djibouti | Venezuela (Bolivarian Republic of) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 81.5% | 42.1% | 39.4% | Djibouti |
| 2020s | 53.6% | 37.0% | 16.6% | Djibouti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Djibouti or Venezuela (Bolivarian Republic of)?
- Venezuela (Bolivarian Republic of), at 51.0% against 48.0% in Djibouti as of 2024.
- What is the difference in proportion of the target population who received between Djibouti and Venezuela (Bolivarian Republic of)?
- 3.0%, with Venezuela (Bolivarian Republic of) ahead.
- How many years of comparable data are there for Djibouti and Venezuela (Bolivarian Republic of)?
- 13 years are reported by both, from 2012 to 2024.
- How do Djibouti and Venezuela (Bolivarian Republic of) rank globally for proportion of the target population who received?
- Djibouti ranks 181st and Venezuela (Bolivarian Republic of) ranks 179th of 193 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.